| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/07/1993 | WO1993000160A1 Multiple emulsions and methods of preparation |
| 01/07/1993 | WO1993000109A1 Method of stimulating immune response using growth hormone |
| 01/07/1993 | WO1993000103A1 Chimeric envelope proteins for viral targeting |
| 01/07/1993 | WO1993000101A1 Nanoparticles based on a polyoxyethylene and polylactic acid block copolymer |
| 01/07/1993 | WO1993000100A2 Wound cleanser |
| 01/07/1993 | WO1993000097A1 Pharmaceutical preparations containing torasemid |
| 01/07/1993 | WO1993000085A1 Stabilized retinoid-containing skin care compositions |
| 01/07/1993 | WO1993000078A1 Molecular encapsulation and delivery of alkanes to living mammalian cells for risk assessment and pharmaceutical application |
| 01/07/1993 | WO1993000077A1 Orally administrable therapeutic proteins and method of making |
| 01/07/1993 | WO1993000076A1 Carrier systems for drugs |
| 01/07/1993 | WO1993000072A1 Process for solubilizing difficultly soluble pharmaceutical actives |
| 01/07/1993 | WO1993000069A1 Vesicles in non-polar media |
| 01/07/1993 | WO1993000064A2 Evaluation and treatment of the multidrug resistance phenotype |
| 01/07/1993 | WO1993000051A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | WO1992019233A3 Sustained release composition and methods of use thereof |
| 01/07/1993 | WO1992019209A3 Taste-masked medicaments and their preparation |
| 01/07/1993 | EP0521799A1 Ophthalmic compositions |
| 01/07/1993 | EP0521692A2 Inhibition of tumor cell metastasis potential and invasiveness by chemically-defined oligosaccharides, their derivatives, mimetics and antibodies directed to them |
| 01/07/1993 | EP0521680A1 3-Oxygermylpropionic acid compressed compositon and its use against cytopathogenic substances |
| 01/07/1993 | EP0521607A1 Composition for enhancing drug permeation |
| 01/07/1993 | EP0521579A2 Stick composition with sodium chloride and stearyl alcohol |
| 01/07/1993 | EP0521562A1 Vesicles in non-polar media |
| 01/07/1993 | EP0521492A2 Perfluoro (ethyldimethylcyclohexane) |
| 01/07/1993 | EP0521398A2 Phospholipids container composition |
| 01/07/1993 | EP0521310A2 Solid dispersion tablets containing 1,4-dihydropyridine derivatives and process for the preparation thereof |
| 01/07/1993 | EP0521070A1 Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief. |
| 01/07/1993 | EP0520983A1 Calcitonin suppository formulations |
| 01/07/1993 | EP0390849B1 Methyl cellulose pharmaceutical composition |
| 01/07/1993 | EP0247142B1 Film-forming, pharmaceutical vehicles for application of medicaments to nails, pharmaceutical compositions based on those vehicles, and methods of using same |
| 01/07/1993 | CA2112376A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | CA2112356A1 Multiple emulsions and methods of preparation |
| 01/07/1993 | CA2112226A1 Purification of recombinant apolipoprotein e from bacteria |
| 01/07/1993 | CA2112123A1 Wound cleanser |
| 01/07/1993 | CA2111683A1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 01/06/1993 | CN1067580A Megestrol acetate formulation |
| 01/06/1993 | CN1067579A Non-chlorofluorocarbon aerosol formulations |
| 01/06/1993 | CN1067578A Non-chlorofluorocarbon aerosol formulations |
| 01/06/1993 | CN1067577A Pharmaceutical formulations |
| 01/06/1993 | CA2073141A1 Ophthalmic compositions |
| 01/05/1993 | US5177110 Injectable parasiticidal composition |
| 01/05/1993 | US5177076 Aqueous folinate solution stable at refrigerator temperature, as well as process for its preparation |
| 01/05/1993 | US5177064 Targeted drug delivery via phosphonate derivatives |
| 01/05/1993 | US5177059 Polymyxin B conjugates |
| 01/05/1993 | US5176918 Topical medicament |
| 01/05/1993 | US5176909 Stable immunogen composition for oral administration |
| 01/05/1993 | US5176907 Used as a drug delivery device and an implant |
| 01/05/1993 | CA1312284C Stressed polymeric device for controlled release of a substance to an ambient environment |
| 01/05/1993 | CA1312281C Transdermal delivery of drugs |
| 01/04/1993 | CA2072850A1 Composition for enhancing drug permeation |
| 01/03/1993 | CA2072315A1 Perfluoroethyldimethyl cyclohexane |
| 01/02/1993 | CA2072824A1 Cluster conjugates of drugs with antibodies |
| 12/30/1992 | EP0520889A1 Process for preparing nanoparticles |
| 12/30/1992 | EP0520888A1 Polyoxyethylene-polylactic acid block copolymer nanoparticles |
| 12/30/1992 | EP0520499A1 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
| 12/30/1992 | EP0520237A2 Bone replacement material containing fibroblast growth factors |
| 12/30/1992 | EP0520112A1 Dermatological composition based on an aqueous phase |
| 12/30/1992 | EP0519926A1 Transdermal system. |
| 12/29/1992 | US5175285 Polymers derived from polysuccinimide, used as surface coatings for medicinals and foods |
| 12/29/1992 | US5175278 Heteropolysaccharide S-657 |
| 12/29/1992 | US5175257 Useful for delivering radioisotopes to desired target sites in vivo |
| 12/29/1992 | US5175235 Polydicarboxylic acid with tricarboxylic acid branching agents for drug delivery |
| 12/29/1992 | US5175152 Treating respiratory system disorders |
| 12/29/1992 | US5175147 Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract |
| 12/29/1992 | US5175000 Free amine benzophenanthridine alkaloid compositions |
| 12/29/1992 | US5174995 Dissolved drug in saturated solution, a solubilizer, water and antinucleant; applying to a water wetted area of body, such as hair or scalp |
| 12/29/1992 | US5174988 Mixing dipalmitoylphosphatidyl chline, cholesteryl palmitate, drug, fluorocarbon propellant; evaporating propellant |
| 12/29/1992 | CA1312016C Osmotic continuous dispensing oral delivery system containing a moderately water-soluble metoprolol salt having improved core composition and use thereof |
| 12/28/1992 | WO1993000106A1 External preparation containing cyclosporin |
| 12/28/1992 | WO1993000006A1 Bioactive composition |
| 12/28/1992 | CA2090480A1 Bioactive composition |
| 12/28/1992 | CA2090417A1 Topical preparations containing cyclosporin |
| 12/27/1992 | WO1993000057A1 Transdermal nicotine absorption dosage unit and process |
| 12/27/1992 | CA2094913A1 Transdermal nicotine absorption dosage unit and process |
| 12/27/1992 | CA2072244A1 Bone replacement material with fgf |
| 12/24/1992 | DE4119890A1 Kosmetische und pharmazeutische oelkomponente Cosmetic and pharmaceutical oelkomponente |
| 12/23/1992 | WO1992022635A1 Targeted delivery of genes encoding secretory proteins |
| 12/23/1992 | WO1992022600A1 Polycarbonates and the use thereof for the preparation of bioerosible matrices |
| 12/23/1992 | WO1992022332A2 Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology |
| 12/23/1992 | WO1992022331A1 Pharmaceutical compositions |
| 12/23/1992 | WO1992022318A1 Amino acid derivative and bromoacetyl modified peptides |
| 12/23/1992 | WO1992022298A1 Novel liposomal drug delivery systems |
| 12/23/1992 | WO1992022288A1 Non-chlorofluorocarbon aerosol formulations |
| 12/23/1992 | WO1992022287A1 Non-chlorofluorocarbon aerosol formulations |
| 12/23/1992 | WO1992022284A1 Oral-administration forms of a medicament containing pantoprazol |
| 12/23/1992 | WO1992022283A1 A process for producing suppositories by compression and suppositories obtained by the process |
| 12/23/1992 | WO1992022282A1 Oil components for cosmetic and pharmaceutical preparations |
| 12/23/1992 | WO1992022249A1 Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes |
| 12/23/1992 | WO1992022247A1 Gas filled liposomes and their use as ultrasonic contrast agents |
| 12/23/1992 | WO1992022202A1 Thrombolytic and perfluorochemical treatment for myocardial infraction |
| 12/23/1992 | WO1992019227A3 Pharmaceutical formulations |
| 12/23/1992 | WO1992016182A3 Method for inactivating enveloped viruses and sperm |
| 12/23/1992 | EP0519820A1 Matrixtablet for the sustained release of indapamide after oral administration |
| 12/23/1992 | EP0519673A1 Composition containing dioxabicyclo[3.3.0]octane derivative |
| 12/23/1992 | EP0519463A1 Synthetic, catalytic oligonucleotides |
| 12/23/1992 | EP0519428A2 Cyclodextrin composition |
| 12/23/1992 | EP0519371A1 Stabilized solid dosage forms of choline metal carboxymethylcellulose salicylate compositions |
| 12/23/1992 | EP0519365A1 Compositions for oral administration containing pantoprazole |
| 12/23/1992 | EP0519351A2 Megestrol acetate formulation |
| 12/23/1992 | EP0519099A1 Direct compression cyclophosphamide tablet |
| 12/23/1992 | EP0518982A1 Method for enhancing antibody transport through capillary barriers |